Login / Signup

Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study.

Alan J KivitzAlvin F WellsJuan de J VargasHerbert S B BarafMaureen RischmuellerJustin KlaffNasser KhanYihan LiKyle CarterAlan FriedmanPatrick Durez
Published in: Rheumatology and therapy (2023)
Trial registration number: NCT02049138.
Keyphrases
  • open label
  • phase iii
  • phase ii
  • clinical trial
  • study protocol
  • randomized controlled trial
  • phase ii study
  • squamous cell carcinoma
  • double blind
  • rectal cancer